Chambal Fertilisers & Chemicals Ltd
Chambal Fertilisers & Chemicals Ltd
ChemicalsKey Fundamentals
SmallcapFertilizersChemicalsInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Chambal Fertilisers & Chemicals Ltd insights
57 extracted metrics + investor summaries across FY11–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
1- Company has been maintaining a healthy dividend payout of 23.5%
Weaknesses
2- The company has delivered a poor sales growth of 10.3% over past five years.
- Debtor days have increased from 16.1 to 36.4 days.
Growth Rate
AI Analysis — Bull vs Bear
Chambal Fertilisers & Chemicals trades at a PE of 9.2x with a market cap of Rs 17,737 Cr, delivering a consistent ROE of ~20% over the last year and 19% over 3-5 year periods. TTM sales grew 16% and profits grew 10%, though the stock has declined 16% over the past year despite longer-term compounding at 21% CAGR over 10 years.
- Attractive valuation at PE of 9.2x, significantly below broader market multiples, suggesting limited downside from valuation compression
- Consistent ROE of 19-22% over 3, 5, and 10-year periods indicates disciplined capital allocation and structural profitability
- 10-year stock CAGR of 21% demonstrates long-term wealth creation track record
- Dividend yield of 2.49% with a healthy payout ratio of 23.5% provides income support and signals management confidence in cash flows
- TTM sales growth of 16% shows a recovery in top-line momentum after a period of decline
- TTM profit growth of 10% confirms earnings resilience even as input costs and subsidy dynamics fluctuate
- Price-to-book ratio of 1.7x is reasonable for a company generating ~20% ROE, suggesting the stock is not overpriced relative to asset base
- 3-year compounded profit growth of 24% demonstrates strong earnings acceleration in the medium term
- 5-year compounded sales growth of only 10% reflects poor top-line expansion in a commodity-linked business
- Stock has declined 16% over the past 1 year, underperforming broader indices and indicating weak near-term sentiment
- 3-year compounded sales growth is negative at -9%, showing revenue contraction over the medium term
- Debtor days have increased from 16.1 to 36.4 days, signaling deteriorating working capital efficiency and potential collection challenges
- 5-year stock CAGR of only 6% suggests prolonged periods of stagnation despite decent earnings growth
- Fertiliser sector is heavily regulated with subsidy dependence, creating policy risk that can impact profitability unpredictably
- 5-year compounded profit growth of only 6% indicates earnings growth has been inconsistent and lumpy over longer horizons
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Tax penalty of ₹96.86 lakh upheld Aug 7
Income Tax Dept upheld ₹96.86 lakh penalty on Chambal Fertilisers for disallowed investment provisions. The company plans to appeal the decision.
- Final dividend ₹6/share recommended Aug 5
Board recommends final dividend of ₹6 per equity share for FY 2025-26, with record date August 11, 2026 and AGM scheduled for September 1, 2026.
- FY26 BRSR report filed Aug 5
Chambal Fertilisers submitted its Business Responsibility and Sustainability Report for FY26 covering environmental metrics, safety records, and governance disclosures.
- Q1FY27 earnings call scheduled Jul 23
Analyst conference call set for July 31, 2026 to discuss Q1FY27 results with senior management including MD and CFO.
TL;DR: Chambal Fertilisers is returning cash to shareholders with a healthy ₹6/share final dividend, signaling confidence in earnings. The ₹96.86 lakh tax penalty is a minor overhang but immaterial relative to company size and is being appealed. No operational or demand-side concerns are visible in recent filings. The near-term catalyst is the Q1FY27 earnings call on July 31, which should provide clarity on fertiliser demand and subsidy flows.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5,589 | 5,386 | 4,349 | 2,643 | 4,933 | 4,346 | 4,918 | 2,449 | 5,698 | 6,413 | 5,898 | 2,785 | 5,027 |
| Expenses | 4,956 | 4,771 | 3,720 | 2,477 | 4,181 | 3,556 | 4,140 | 2,285 | 4,937 | 5,571 | 5,078 | 2,530 | 4,201 |
| Operating Profit | 633 | 615 | 628 | 166 | 752 | 790 | 778 | 163 | 761 | 842 | 821 | 255 | 826 |
| OPM % | 11% | 11% | 14% | 6% | 15% | 18% | 16% | 7% | 13% | 13% | 14% | 9% | 16% |
| Other Income | 14 | 90 | 151 | 73 | 86 | 80 | 95 | 86 | 79 | 88 | 36 | 53 | 27 |
| Interest | 55 | 46 | 36 | 36 | 40 | 1 | 7 | 0 | 2 | 1 | 1 | 3 | 17 |
| Depreciation | 77 | 78 | 79 | 78 | 82 | 83 | 83 | 82 | 84 | 87 | 88 | 90 | 89 |
| PBT | 516 | 581 | 664 | 126 | 716 | 786 | 783 | 168 | 754 | 842 | 768 | 215 | 747 |
| Tax % | 34% | 34% | 31% | 23% | 37% | 32% | 32% | 22% | 27% | 23% | 24% | 21% | 30% |
| Net Profit | 339 | 381 | 459 | 97 | 448 | 536 | 534 | 130 | 549 | 649 | 586 | 169 | 524 |
| EPS in Rs | 8.14 | 9.15 | 11.04 | 2.42 | 11.19 | 13.39 | 13.34 | 3.25 | 13.7 | 16.19 | 14.64 | 4.22 | 13.07 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9,733 | 9,008 | 7,553 | 7,541 | 10,095 | 12,206 | 12,719 | 16,069 | 27,773 | 17,966 | 16,646 | 20,794 | 20,123 |
| Expenses | 8,996 | 8,354 | 6,795 | 6,730 | 8,894 | 10,281 | 10,249 | 13,804 | 25,951 | 15,919 | 14,145 | 18,100 | 17,380 |
| Operating Profit | 737 | 654 | 759 | 811 | 1,200 | 1,925 | 2,470 | 2,265 | 1,822 | 2,047 | 2,501 | 2,694 | 2,743 |
| OPM % | 8% | 7% | 10% | 11% | 12% | 16% | 19% | 14% | 7% | 11% | 15% | 13% | 14% |
| Other Income | 103 | 32 | 133 | 172 | -2 | 192 | 470 | 374 | 222 | 326 | 329 | 240 | 203 |
| Interest | 164 | 267 | 255 | 157 | 247 | 504 | 291 | 109 | 320 | 173 | 48 | 7 | 21 |
| Depreciation | 216 | 111 | 92 | 85 | 119 | 287 | 289 | 300 | 308 | 313 | 330 | 349 | 354 |
| PBT | 459 | 308 | 544 | 740 | 832 | 1,327 | 2,360 | 2,231 | 1,416 | 1,887 | 2,452 | 2,578 | 2,572 |
| Tax % | 39% | 52% | 34% | 33% | 30% | 8% | 26% | 30% | 27% | 32% | 33% | 24% | — |
| Net Profit | 280 | 147 | 359 | 495 | 585 | 1,226 | 1,748 | 1,566 | 1,034 | 1,276 | 1,649 | 1,953 | 1,928 |
| EPS in Rs | 7.08 | 5.31 | 8.7 | 11.99 | 14.18 | 29.46 | 39.76 | 37.62 | 24.85 | 31.84 | 41.17 | 48.76 | 48.12 |
| Div. Payout % | 27% | 36% | 22% | 16% | 14% | 14% | 19% | 20% | 30% | 24% | 24% | 23% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 414 | 416 | 416 | 416 | 416 | 416 | 416 | 416 | 416 | 401 | 401 | 401 |
| Reserves | 1,837 | 1,451 | 1,707 | 2,089 | 2,467 | 3,123 | 4,833 | 5,983 | 6,652 | 6,873 | 8,327 | 10,007 |
| Borrowings | 4,089 | 5,317 | 4,619 | 6,079 | 9,045 | 10,113 | 3,936 | 4,337 | 3,358 | 1,874 | 99 | 1,068 |
| Other Liabilities | 1,298 | 939 | 1,315 | 877 | 1,997 | 880 | 1,062 | 2,553 | 2,344 | 2,361 | 2,580 | 2,927 |
| Total Liabilities | 7,638 | 8,123 | 8,057 | 9,462 | 13,925 | 14,533 | 10,247 | 13,289 | 12,770 | 11,509 | 11,407 | 14,402 |
| Fixed Assets | 2,948 | 1,793 | 1,162 | 1,234 | 6,905 | 6,701 | 6,480 | 6,358 | 6,262 | 6,423 | 6,221 | 6,110 |
| CWIP | 119 | 639 | 1,712 | 4,135 | 121 | 85 | 161 | 157 | 103 | 184 | 650 | 1,389 |
| Investments | 30 | 211 | 174 | 207 | 300 | 217 | 298 | 559 | 2,377 | 2,431 | 1,372 | 1,081 |
| Other Assets | 4,541 | 5,480 | 5,009 | 3,886 | 6,598 | 7,529 | 3,308 | 6,215 | 4,028 | 2,471 | 3,164 | 5,823 |
| Total Assets | 7,638 | 8,123 | 8,057 | 9,462 | 13,925 | 14,533 | 10,247 | 13,289 | 12,770 | 11,509 | 11,407 | 14,402 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 1,064 | -27 | 1,280 | 1,172 | -1,130 | 827 | 6,944 | -24 | 3,239 | 3,327 | 1,394 | 138 |
| Investing | -149 | -348 | -703 | -1,784 | -1,132 | -462 | -195 | -119 | -1,872 | -382 | 739 | -481 |
| Financing | -937 | 362 | -500 | 564 | 2,263 | -283 | -6,007 | -213 | -1,862 | -2,871 | -2,135 | 543 |
| Net Cash Flow | -22 | -12 | 76 | -49 | 2 | 82 | 742 | -356 | -495 | 73 | -2 | 200 |
| Free Cash Flow | 878 | -665 | 400 | -1,250 | -2,334 | 177 | 6,708 | -188 | 3,045 | 2,718 | 824 | -754 |
| CFO/OP | 159 | 17 | 191 | 170 | -76 | 56 | 295 | 14 | 193 | 179 | 71 | 32 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 119 | 156 | 147 | 123 | 175 | 166 | 34 | 49 | 23 | 4 | 8 | 36 |
| Inventory Days | 48 | 55 | 65 | 63 | 79 | 60 | 39 | 119 | 25 | 42 | 71 | 63 |
| Days Payable | 23 | 28 | 18 | 24 | 59 | 29 | 19 | 57 | 22 | 27 | 25 | 26 |
| Cash Conversion Cycle | 144 | 183 | 193 | 161 | 195 | 198 | 54 | 111 | 26 | 19 | 54 | 73 |
| Working Capital Days | 4 | 8 | 17 | 19 | -5 | 14 | 21 | 39 | 8 | 0 | 30 | 41 |
| ROCE % | 9% | 10% | 11% | 12% | 12% | 14% | 20% | 23% | 16% | 20% | 27% | 25% |
Documents
Frequently Asked Questions about Chambal Fertilisers & Chemicals Ltd
What does Chambal Fertilisers & Chemicals Ltd do?
Where is Chambal Fertilisers & Chemicals Ltd (CHAMBLFERT) listed?
Which sector does Chambal Fertilisers & Chemicals Ltd belong to?
What is the market capitalisation of Chambal Fertilisers & Chemicals Ltd?
What is the PE ratio of Chambal Fertilisers & Chemicals Ltd?
What is the 52-week high and low of Chambal Fertilisers & Chemicals Ltd?
Does Chambal Fertilisers & Chemicals Ltd pay dividends?
What is the Return on Equity (ROE) of Chambal Fertilisers & Chemicals Ltd?
How can I research Chambal Fertilisers & Chemicals Ltd on Tapetide?
Company Information
Chambal Fertilisers & Chemicals Ltd is engaged in production of Urea from its own manufacturing plants. It also markets/ deals in other fertilisers and agri-inputs. It also has a Joint Venture for manufacture of Phospohric Acid in Morocco. The company was also engaged in Software business, However, in FY21, it sold assets and transferred certain liabilities of the business to cease the operations of the software business.[1]